Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 13-Aug-24 4:15 PM View:  | Schmid John P. Director | Xeris Biopharma Holdings, I... (XERS) | 12-Aug-24 | Market Purchase | 4,515 | $2.25 | $10,147.00 | 3% 133.84K to 138.36K | 9% |
| 12-Aug-24 6:28 PM View: | Schmid John P. Director | Xeris Biopharma Holdings, I... (XERS) | 09-Aug-24 | Market Purchase | 4,285 | $2.37 | $10,134.00 | 3% 129.56K to 133.84K | 3% |
| 02-Aug-24 5:22 PM View: | McCulloch Kevin See Remarks | Xeris Biopharma Holdings, I... (XERS) | 01-Aug-24 | Grant | 150,000 | -- | -- | 10% 1.45M to 1.6M | |
| 02-Aug-24 5:22 PM View: | Shannon John Patrick Jr See Remarks Director | Xeris Biopharma Holdings, I... (XERS) | 01-Aug-24 | Grant | 250,000 | -- | -- | 12% 2.17M to 2.42M | |
| 09-Aug-24 4:06 PM View: | Pieper Steven See Remarks | Xeris Biopharma Holdings, I... (XERS) | 28-Jul-24 | Payment of Exercise | 14,767 | $2.61 | $38,541.90 | (1%) 1.44M to 1.42M | |
| 05-Jun-24 4:18 PM View: | Halkuff Dawn Director | Xeris Biopharma Holdings, I... (XERS) | 05-Jun-24 | Grant | 50,000 | -- | -- | 79% 62.91K to 112.91K | |
| 05-Jun-24 4:18 PM View: | Persky Marla Director | Xeris Biopharma Holdings, I... (XERS) | 05-Jun-24 | Grant | 50,000 | -- | -- | 78% 63.87K to 113.87K | |
| 05-Jun-24 4:18 PM View: | Johnson John H Director | Xeris Biopharma Holdings, I... (XERS) | 05-Jun-24 | Grant | 50,000 | -- | -- | 6% 840.98K to 890.98K | |
| 05-Jun-24 4:19 PM View: | Fairley Ricki Louise Director | Xeris Biopharma Holdings, I... (XERS) | 05-Jun-24 | Grant | 50,000 | -- | -- | 59% 85.0K to 135.0K | |
| 05-Jun-24 4:19 PM View: | Sherman Jeffrey W Director | Xeris Biopharma Holdings, I... (XERS) | 05-Jun-24 | Grant | 50,000 | -- | -- | 42% 119.78K to 169.78K | |
| 05-Jun-24 4:19 PM View: | Bormann-Kennedy Barbara-Jea... Director | Xeris Biopharma Holdings, I... (XERS) | 05-Jun-24 | Grant | 50,000 | -- | -- | 87% 57.5K to 107.5K | |
| 05-Jun-24 4:19 PM View: | Schmid John P. Director | Xeris Biopharma Holdings, I... (XERS) | 05-Jun-24 | Grant | 50,000 | -- | -- | 63% 79.56K to 129.56K | |
| 05-Jun-24 4:18 PM View: | Kong Garheng Director | Xeris Biopharma Holdings, I... (XERS) | 05-Jun-24 | Grant | 50,000 | -- | -- | 44% 114.14K to 164.14K | |
| 10-May-24 4:04 PM View: | Schmid John P. Director | Xeris Biopharma Holdings, I... (XERS) | 10-May-24 | Private Purchase | 5,400 | $1.91 | $10,314.00 | 7% 74.16K to 79.56K | |
| 18-Mar-24 5:32 PM View: | Johnson John H Director | Xeris Biopharma Holdings, I... (XERS) | 18-Mar-24 | Option Exercise | 215,600 | $1.99 | $429,044.00 | 40% 535.81K to 751.41K | |
| 01-Apr-24 5:43 PM View: | Johnson John H Director | Xeris Biopharma Holdings, I... (XERS) | 15-Mar-24 | Acquisition (other) | 89,571 | -- | -- | 12% 751.41K to 840.98K | |
| 01-Apr-24 5:45 PM View: | Kong Garheng Director | Xeris Biopharma Holdings, I... (XERS) | 15-Mar-24 | Acquisition (other) | 6,474 | -- | -- | 6% 107.67K to 114.14K | |
| 11-Apr-24 4:05 PM View: | Sherman Jeffrey W Director | Xeris Biopharma Holdings, I... (XERS) | 15-Mar-24 | Acquisition (other) | 6,502 | -- | -- | 6% 113.28K to 119.78K | |
| 14-Mar-24 9:03 PM View: | Schmid John P. Director | Xeris Biopharma Holdings, I... (XERS) | 14-Mar-24 | Private Purchase | 4,500 | $2.16 | $9,720.00 | 6% 69.66K to 74.16K | |
| 09-Aug-24 4:06 PM View: | Pieper Steven See Remarks | Xeris Biopharma Holdings, I... (XERS) | 31-Jan-24 | Payment of Exercise | 110,750 | $2.46 | $272,445.00 | (7%) 1.55M to 1.44M | |
| 31-Jan-24 5:05 PM View: | Shannon John Patrick Jr See Remarks Director | Xeris Biopharma Holdings, I... (XERS) | 31-Jan-24 | Grant | 750,000 | -- | -- | 53% 1.41M to 2.16M | |
| 31-Jan-24 5:05 PM View: | Pieper Steven See Remarks | Xeris Biopharma Holdings, I... (XERS) | 31-Jan-24 | Grant | 450,000 | -- | -- | 38% 1.18M to 1.63M | |
| 31-Jan-24 5:04 PM View: | Johnson Kenneth Erland See Remarks | Xeris Biopharma Holdings, I... (XERS) | 31-Jan-24 | Grant | 175,000 | -- | -- | 64% 271.86K to 446.86K | |
| 02-Aug-24 5:22 PM View: | Shannon John Patrick Jr See Remarks Director | Xeris Biopharma Holdings, I... (XERS) | 31-Jan-24 | Payment of Exercise | 110,750 | $2.46 | $272,445.00 | (5%) 2.26M to 2.15M | |
| 31-Jan-24 5:04 PM View: | Edick Paul R See Remarks Director | Xeris Biopharma Holdings, I... (XERS) | 31-Jan-24 | Grant | 1,500,000 | -- | -- | 65% 2.32M to 3.82M | |
| 31-Jan-24 5:04 PM View: | Hecht Beth See Remarks | Xeris Biopharma Holdings, I... (XERS) | 31-Jan-24 | Grant | 750,000 | -- | -- | 93% 804.97K to 1.55M | |
| 02-Aug-24 5:22 PM View: | Shannon John Patrick Jr See Remarks Director | Xeris Biopharma Holdings, I... (XERS) | 29-Jan-24 | Payment of Exercise | 22,150 | $2.66 | $58,919.00 | (< 1%) 2.28M to 2.26M | |
| 09-Aug-24 4:06 PM View: | Pieper Steven See Remarks | Xeris Biopharma Holdings, I... (XERS) | 29-Jan-24 | Payment of Exercise | 4,379 | $2.66 | $11,648.10 | (< 1%) 1.55M to 1.55M | |
| 09-Aug-24 4:06 PM View: | Pieper Steven See Remarks | Xeris Biopharma Holdings, I... (XERS) | 03-Jan-24 | Payment of Exercise | 23,067 | $2.24 | $51,670.10 | (1%) 1.58M to 1.55M | |
| 02-Aug-24 5:22 PM View: | Shannon John Patrick Jr See Remarks Director | Xeris Biopharma Holdings, I... (XERS) | 03-Jan-24 | Payment of Exercise | 40,834 | $2.24 | $91,468.20 | (2%) 2.32M to 2.28M | |
| 29-Nov-23 4:09 PM View: | Sherman Jeffrey W Director | Xeris Biopharma Holdings, I... (XERS) | 27-Nov-23 | Private Purchase | 5,400 | $1.87 | $10,098.00 | 5% 107.88K to 113.28K | |
| 21-Nov-23 4:16 PM View: | Pieper Steven See Remarks | Xeris Biopharma Holdings, I... (XERS) | 20-Nov-23 | Private Purchase | 28,000 | $1.95 | $54,600.00 | 2% 1.15M to 1.18M | |
| 21-Nov-23 4:20 PM View: | Halkuff Dawn Director | Xeris Biopharma Holdings, I... (XERS) | 20-Nov-23 | Private Purchase | 5,410 | $1.84 | $9,954.40 | 9% 57.5K to 62.91K | |
| 17-Nov-23 5:58 PM View: | Shannon John Patrick Jr See Remarks Director | Xeris Biopharma Holdings, I... (XERS) | 17-Nov-23 | Private Purchase | 30,769 | $1.64 | $50,399.60 | 2% 1.38M to 1.41M | |
| 17-Nov-23 6:35 PM View: | Schmid John P. Director | Xeris Biopharma Holdings, I... (XERS) | 16-Nov-23 | Private Purchase | 6,500 | $1.51 | $9,815.00 | 10% 63.16K to 69.66K | |
| 15-Nov-23 4:13 PM View: | Persky Marla Director | Xeris Biopharma Holdings, I... (XERS) | 14-Nov-23 | Private Purchase | 6,370 | $1.58 | $10,057.60 | 11% 57.5K to 63.87K | |
| 09-Aug-23 6:57 PM View: | Edick Paul R See Remarks Director | Xeris Biopharma Holdings, I... (XERS) | 09-Aug-23 | Market Purchase | 10,000 | $2.38 | $23,794.00 | < 1% 2.31M to 2.32M | 3% |
| 09-Aug-24 4:06 PM View: | Pieper Steven See Remarks | Xeris Biopharma Holdings, I... (XERS) | 28-Jul-23 | Payment of Exercise | 10,200 | $2.53 | $25,806.00 | (< 1%) 1.59M to 1.58M | |
| 07-Jun-23 4:59 PM View: | Johnson John H Director | Xeris Biopharma Holdings, I... (XERS) | 07-Jun-23 | Grant | 42,500 | -- | -- | 9% 493.31K to 535.81K | |
| 07-Jun-23 5:00 PM View: | Kong Garheng Director | Xeris Biopharma Holdings, I... (XERS) | 07-Jun-23 | Grant | 42,500 | -- | -- | 65% 65.17K to 107.67K | |
| 07-Jun-23 4:52 PM View: | Sherman Jeffrey W Director | Xeris Biopharma Holdings, I... (XERS) | 07-Jun-23 | Grant | 42,500 | -- | -- | 65% 65.38K to 107.88K | |
| 07-Jun-23 4:55 PM View: | Schmid John P. Director | Xeris Biopharma Holdings, I... (XERS) | 07-Jun-23 | Grant | 42,500 | -- | -- | 206% 20.66K to 63.16K | |
| 07-Jun-23 5:02 PM View: | Bormann-Kennedy Barbara-Jea... Director | Xeris Biopharma Holdings, I... (XERS) | 07-Jun-23 | Grant | 42,500 | -- | -- | 283% 15.0K to 57.5K | |
| 07-Jun-23 4:58 PM View: | Halkuff Dawn Director | Xeris Biopharma Holdings, I... (XERS) | 07-Jun-23 | Grant | 42,500 | -- | -- | 283% 15.0K to 57.5K | |
| 07-Jun-23 4:56 PM View: | Persky Marla Director | Xeris Biopharma Holdings, I... (XERS) | 07-Jun-23 | Grant | 42,500 | -- | -- | 283% 15.0K to 57.5K | |
| 29-Mar-23 4:53 PM View: | Fairley Ricki Louise Director | Xeris Biopharma Holdings, I... (XERS) | 27-Mar-23 | Grant | 85,000 | -- | -- | 100% 0 to 85.0K | |
| 01-Feb-23 4:12 PM View: | Johnson Kenneth Erland See Remarks | Xeris Biopharma Holdings, I... (XERS) | 31-Jan-23 | Grant | 100,000 | -- | -- | 59% 169.78K to 269.78K | |
| 02-Aug-24 5:22 PM View: | Shannon John Patrick Jr See Remarks Director | Xeris Biopharma Holdings, I... (XERS) | 31-Jan-23 | Payment of Exercise | 9,880 | $1.24 | $12,251.20 | (< 1%) 2.33M to 2.32M | |
| 01-Feb-23 4:12 PM View: | Hecht Beth See Remarks | Xeris Biopharma Holdings, I... (XERS) | 31-Jan-23 | Grant | 350,000 | -- | -- | 78% 447.76K to 797.76K | |
| 01-Feb-23 4:13 PM View: | Edick Paul R See Remarks Director | Xeris Biopharma Holdings, I... (XERS) | 31-Jan-23 | Grant | 750,000 | -- | -- | 48% 1.56M to 2.31M |
